Accueil>>NNEI 2'-indazole isomer

NNEI 2'-indazole isomer

Catalog No.GC41260

NNEI is an analog of JWH 018, an aminoalkylindole-based synthetic cannabinoid that has been identified in smoking mixtures.

Products are for research use only. Not for human use. We do not sell to patients.

NNEI 2'-indazole isomer Chemical Structure

Taille Prix Stock
1mg
111,00 $US
Please Inquire
5mg
445,00 $US
Please Inquire
50mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

NNEI is an analog of JWH 018 , an aminoalkylindole-based synthetic cannabinoid that has been identified in smoking mixtures. NNEI 2'-indazole isomer is an indazole analog of NNEI with the alkyl group at the two position. This compound is a close analog of MN-18 , which is also an indazole-based cannabinoid but has the alkyl group at the one position. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications. This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.

Avis

Review for NNEI 2'-indazole isomer

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for NNEI 2'-indazole isomer

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.